q&more
My watch list
my.chemie.de  
Login  

Author

Prof. Dr. Peter Seeberger

Max-Planck-Institut für Kolloid- und Grenzflächenforschung, Abteilung Biomolekulare Systeme

born 1966, studied chemistry at the University of Erlangen-Nuremberg, and received his doctorate in biochemistry from the University of Colorado. After holding a post-doctorate position at the Sloan-Kettering Institute for Cancer Research in New York City, he was Assistant Professor and Firmenich Associate Professor at the Massachusetts Institute of Technology (MIT) in Cambridge, USA from 1998 – 2002. Between 2003 and 2009, he was a Professor at the Swiss Federal Institute of Technology (ETH) Zurich. Since 2009, he has held the position of Director of the Department of Bio­molecular Systems at the Max Planck Institute of Colloids and Interfaces in Potsdam, and Professor at the Freie Universität Berlin. His working group researches in the border area between chemistry and biology. In addition to ground-breaking inventions in the area of automatic syntheses of complex sugars, he is developing new synthesis methods (microreactors, among others) for the complete synthesis of biologically active compounds.

Facts, background information, dossiers

Other articles by this author

All articles

With Light in the Fight against Malaria

Malaria represents a global threat to health, which is difficult to keep under control. Amongst more than 200 million sufferers, over 500,000 die each year of the disease, with the risk of (…)

More about MPI für Kolloid- und Grenzflächenforschung

  • News

    Stiff fibres spun from slime

    Nature is an excellent teacher – even for material scientists. Researchers, including scientists at the Max Planck Institute of Colloids and Interfaces, have now observed a remarkable mechanism by which polymer materials are formed. In order to capture prey, velvet worms shoot out a sticky ... more

    An assembly line for medications

    Researchers at the Max Planck Institute of Colloids and Interfaces (MPICI) and the Freie Universität Berlin have succeeded in developing better methods of producing APIs (active pharmaceutical ingredients). As a result, Efavirenz, one of the preferred agents for treating HIV in combination ... more

  • q&more articles

    With Light in the Fight against Malaria

    Malaria represents a global threat to health, which is difficult to keep under control. Amongst more than 200 million sufferers, over 500,000 die each year of the disease, with the risk of a fatal outcome being particularly high in children [1]. more

  • Authors

    Dr. Daniel Kopetzki

    born 1983, studied chemistry at the University of Regensburg and received his doctorate from the Max Planck Institute of Colloids and Interfaces in Potsdam, in the Department of Colloid Chemistry. Since Sept. 2011, he has been working as a post-doctoral fellow for Prof. Dr. Seeberger at the ... more

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by:

 

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE